Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,552.42
(
-0.43%
)
US TECH 100
23,383.20
(
-0.58%
)
Dow Jones
46,105.76
(
-0.22%
)
Brent Oil
100.40
(
3.72%
)
Bitcoin
69,293.00
(
-2.27%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: waynebio post# 1787

Tuesday, 11/07/2006 9:58:05 PM

Tuesday, November 07, 2006 9:58:05 PM

Post# of 19309
>What would stop Merck (with bio engineered yeast) from also getting approval and selling AT if GTCB gets approval in US for HD or in Europe for DIC?<

Following up on urche’s comments, the HD indication is too small a market to attract other players. DIC, on the other hand, will attract other players—indeed there already is a serious competitor in Artisan Pharma’s thrombomodulin (#msg-14524596). If you are going to worry about competition, that’s the place to focus, IMO. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today